• Nootropic Choline Glycerophosphate Powder Pharmaceutical Raw Material CAS 28319-77-9

Nootropic Choline Glycerophosphate Powder Pharmaceutical Raw Material CAS 28319-77-9

stars, based on ( 0 )reviews
$1.00 kilogram
0items available

We are factory from China.We make Nootropics raw material.


We can also make capsules, tablets, and liquid drops. Customers brand is accpetable.


Our email is sales@sarms4muscle.com


1.Basic Info.

 

Product Name: Choline Glycerophosphate
Synonyms:hydroxide,innersalt,(r)-;2-(((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)
-n,n,n-trimethyl-ethanaminiu;glycerophosphocholine;hydroxide,2,3-dihydroxypropylhydrogenphosphate,innersalt,d-cholin;l-alpha-glycerophosphocholine;SN-GLYCERO-3-PHOSPHOCHOLINE;SN-GLYCERO-3-PHOSPHOCHOLINE INNER SALT;SN-GLYCEROPHOSPHORYLCHOLINE (EGG)
CAS: 28319-77-9
MF:C8H20NO6P
MW: 257.22
EINECS:248-962-2
Pakcage : 1kg/5kg/25kg/package
Purity : 99%
Product Categories:Activity Other;Activity;Enzyme Substrates;Smart drug;pharmaceutical ingredients;GPC
Chemical Properties : White powders
Usage : Health care products , nutrition supplements , protect the brain, enhance memory.

 

2.Product Description:

 

Alpha GPC (alpha glycerylphosphorylcholine, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which may have potential for the treatment of Alzheimer's disease and other dementias.

 

Alpha-GPC rapidly delivers choline to the brain across the blood-brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries and in the United States it is classified as generally recognized as safe (GRAS).

 

3.Product Applications:

 

Alpha GPC 28319-77-9 rapidly delivers choline to the brain across the blood-brain barrier and is a biosynthetic precursor of the acetylcholine neurotransmitter.Alpha GPC is derived from highly purified soy lecithin by companies like Lipoid, VAV Life Sciences, Chemi SPA etc.


Studies have investigated its efficacy for cognitive disorders including stroke and Alzheimer's Disease. An Italian multicentre clinical trial on 2,044 patients suffering from recent stroke were supplied alpha-GPC in doses of 1,000 mg/day for 28 days and 400 mg three times per day for the five ensuing months. The trial confirmed the therapeutic role of alpha-GPC on the cognitive recovery of patients based on four measurement scales, three of which reached statistical significance.
Commonly used doses are 300-1,200 mg daily.

 

Function:
1. Increase human Growth
2. Improve mental focus and cognitive function.
3. Improve strengh.

Recent Reviews
+